Blog - Page 3213 of 5757

MondaySep 10, 2012 1:16 pm

Senesco Technologies, Inc. (SNT) Reports Combining SNS01-T with Bortezomib Substantially Increases Effectiveness in Model of Multiple Myeloma

Senesco Technologies announced that the combination of bortezomib – the active component of VELCADE marketed by Millenium: The Takeda Oncology Company – and SNS01-T, which is the subject of Senesco’s ongoing multiple myeloma clinical study, results in substantially better performance in mouse xenograft models than either treatment by itself. SNS01-T enhances bortezomib’s ability to inhibit tumor growth in the mouse model and could potentially be a means of lowering the dose and reducing the severity of treatment-related side effects of bortezomib. As treatment increasingly involves combination therapy, it is important for SNS01-T to work well when added to current multiple…

MondaySep 10, 2012 11:25 am

Teletouch Communications, Inc. (TLLE) Holds Shareholder Conference Call Covering 4th Quarter and Year End Financial Results and Operations

Teletouch Communications, Texas-based cellular services provider and growing consumer electronics distributor, recently held a shareholder conference call highlighting previously released financial results for the 4th fiscal quarter and fiscal year ending June 7, 2012, along with a number of operational issues. The call included Robert McMurrey (Chairman and CEO of Teletouch), Thomas “Kip” Hyde, Jr. (President & COO, and CEO of primary operating company PCI Hawk Electronics), Douglas Sloan (CFO), and Mike Dickens (Sr. VP of Operations). The core of the presentation dealt with the company’s move back to profitability and growth, coming out of a particularly challenging year involving…

MondaySep 10, 2012 10:12 am

ImageWare Systems, Inc. (IWSY) Video Chart for Monday, September 10, 2012

IWSY has climbed above a resistance point at 90 cents and is holding over the 50 and 200 day moving averages. A thinly-traded stock, its volume was up substantially last week as the stock approaches resistance at $1.00. The chart is on watch to hold the support at 90 cents as it tries to break the resistance. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

MondaySep 10, 2012 9:59 am

StrongBox From Crossroads Systems, Inc. (CRDS) Receives Prestigious HPA Engineering Excellence Award for 2012

Crossroads Systems, a provider of data protection and storage solutions worldwide, announced that its StrongBox® LTFS NAS archive solution has received the 2012 HPA Engineering Excellence Award. The prestigious award is a marquee portion of the HPA Awards, which have gradually become the standard against which creative and technical excellence in the art, science, and quality of post production is measured. The winners are chosen from a sizeable field of various technology offerings, including some of the most prominent companies in the industry. StrongBox is an enterprise-level offering that allows tape storage to perform exactly like disk-based storage by leveraging…

MondaySep 10, 2012 9:55 am

Command Center, Inc. (CCNI) Deploys 800 Workers to Aid in Hurricane Relief

Command Center, a provider of on-demand and temporary staffing solutions in the United States, has announced that approximately 800 of its workers are already on hand and helping daily to assist with Hurricane Isaac relief efforts in Louisiana and Mississippi. Command Center’s workers are currently servicing around 20 project locations, engaged in shifts of up to 12 hours to help bring relief to the affected communities as soon as possible. The number of workers from the company is expected to grow in the coming days as water begins to recede in certain other areas. This is the single largest relief…

MondaySep 10, 2012 9:32 am

TNI BioTech Inc. (TNIB) Able to Target Numerous Fatal Diseases with Immunology Approach

TNI BioTech aims for world leadership in the area of immunology. It plans to fight infectious diseases by using Methionine Enkephalin (MENK), a human hormone produced naturally by the human immune system. It is believed that MENK is toxic to tumor cells but does not hurt the human body. TNIB’s most advanced clinical programs involve immunotherapy that works by isolating a patient’s lymphocytes and then incubating them together with an enriching external incubation system. After incubation, the patient’s lymphocytes are reinfused back into the patient where they combat and destroy tumor cells. Although TNIB considers any condition that results in…

FridaySep 07, 2012 4:08 pm

AxoGen, Inc. (AXGN) Peripheral Nerve Repair Submission Receives Outstanding CTBS Abstract Award

AxoGen, a company engaged in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that its submission on findings from the RANGER™ Registry, an on-going study for the Avance® Nerve Graft, was selected for an Outstanding CTBS Abstract Award and was accepted for poster display at the American, Keystone, Colo., September 8-10, 2012. Titled “Clinical Results from a Multicenter Registry Study on the Use of Processed Nerve Allograft for Sensory, Mixed and Motor Nerve Repairs,” the abstract demonstrates the successful recovery of 87 percent of cases involving 66 patients and 92 injuries suffering peripheral nerve repair.…

FridaySep 07, 2012 2:46 pm

Sprott Resource Lending Corp. (SILU) Continues Monetizing Real Estate Portfolio, Completes Castle Mountain Sale

Sprott Resource Lending, the Toronto-headquartered specialist lender to companies in the natural resource development space, reported finalizing the sale of the company's 75% interest in Castle Mountain Venture (CMV) today via the sale of CMV's wholly-owned subsidiary, Viceroy Gold Corp. Castle Mountain Venture controls the formerly operating Castle Mountain gold mine in California. Part of the purchase price was secured at closing of the deal as the private Canadian gold explorer, Telegraph Gold Inc., which has considerable mineral assets in CA, issued 4M shares of common stock (9.4% of current issued/outstanding). With the balance of the purchase price slated to…

FridaySep 07, 2012 12:40 pm

Pengram Corp. (PNGM) Spammed Aggressively

We have observed emails spamming Pengram Corp. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net Let us hear your thoughts below:

FridaySep 07, 2012 10:35 am

Imprimis Pharmaceuticals, Inc. (IMMY) Announces Drug Development Agreement

Imprimis Pharmaceuticals is a specialty pharmaceutical company developing non-invasive, topically delivered products. Its innovative and patented Accudel cream formulation technology is designed to enable highly-targeted, site-specific treatment. Its lead drug candidate, Imprimis – a topical, non-steroidal anti-inflammatory cream – is expected to enter Phase 3 clinical trials in early 2013. The company's drug development strategy calls for repurposing or reformatting existing FDA-approved generic drugs to create new high-value, FDA-approved manufactured drugs that address new therapeutic applications. In other words, generic drugs would be combined with Imprimis' technology to create brand new medications targeted at markets with a specific need. Imprimis…

Site Search

Company Search